Johnson & Johnson’s subcutaneous Tremfya holds potential to set new standard in Crohn’s disease… EP News Bureau Oct 21, 2024 Tremfya's subcutaneous formulation may offer new flexibility for Crohn's disease treatment, positioning it as a key contender in…
Indian Patent Office rejects J&J’s plea to extend monopoly on bedaquiline, MSF lauds move EP News Bureau Mar 24, 2023 J&J must not block the supply of more affordable generic versions of bedaquiline to high TB burden countries and stand by its…
Walmart, CVS and Rite Aid pull 22-ounce J&J baby powder off shelves Reuters Oct 25, 2019 CVS Health Corp said on Thursday it would remove the bottles from its online store as well, out of caution and to prevent customer…
